Abstract:STUDY QUESTIONDo microRNAs (miRNAs) contribute to human early pregnancy loss (EPL)?SUMMARY ANSWERmiR-378a-3p expression is regulated by progesterone and is down-regulated in ducidua of EPL patients which may contribute to decidual apoptosis through Caspase-3 activation.WHAT IS KNOWN ALREADYA variety of miRNAs have been demonstrated to be associated with the development of decidualization and placental formation. However, little has been reported on the roles of miRNA in the pathogenesis of EPL.STUDY DESIGN, SIZE, DURATIONNormal and EPL decidual tissues were collected from patients with normal pregnancies undergoing elective termination of gestation, and from patients with EPL, respectively.PARTICIPANTS/MATERIALS, SETTING, METHODSmiRNA microarrays were used to identify the differentially expressed miRNAs between normal and EPL decidua, and miRNA expression was confirmed by qRT-PCR, qRT-PCR, western blotting and luciferase reporter assays were employed to validate the downstream targets of miR-378a-3p. The effects of miR-378a-3p were evaluated using miR-378a-3p-transfected decidual cells.MAIN RESULTS AND THE ROLE OF CHANCEOf note, 32 up-regulated miRNAs and 38 down-regulated miRNAs were identified by microarray analysis when comparing EPL to normal decidua. MiR-378a-3p was significantly down-regulated in the EPL decidua and was found to inversely regulate the expression of Caspase-3 by directly binding to its 3'-UTRs. In decidual cells, transfection of miR-378a-3p mimics resulted in the inhibition of cell apoptosis and in the increase of cell proliferation through Caspase-3 suppression. Moreover, we found that progesterone could induce the expression of miR-378a-3p in decidual cells.LIMITATIONS, REASONS FOR CAUTIONThis study focused on the function of miR-378a-3p and its target Caspase-3, however, numerous other targets and miRNAs may also be responsible for the pathogenesis of EPL. Therefore, further studies are required to elucidate the role of miRNAs in EPL.WIDER IMPLICATIONS OF THE FINDINGSOur findings indicate that miR-378a-3p may contribute to the development of EPL, and that it could serve as a new potential predictive and therapeutic target of progesterone-treatment for EPL.STUDY FUNDING/COMPETING INTERESTThis study was supported by National Basic Research Program of China (No.2012CB944900); National Science Foundation of China (No.31471405 and 81490742, No.81361120246); The National Science and Technology Support Program (No.2012BA132B00). Authors declare no competing interests.

Effect of Mifepristone on Transforming Growth Factor-β and Its Receptor Transcription in Decidua, Villi and Serum Tumor Necrosis Factor -Α Level in Early Human Gestation

The Retrospective Analysis on the Influence of Taking Mifepristone and Misoprostol During First-trimester Pregnancy and Its Following Impact on Tissue Residual After Induced Abortion

Probe into the Effect of Mifepristone on Angiogenesis of Human Chorionic Villi and Decidual Cells

The Effect of Mifepristone on the Expression of Insulin-Like Growth Factor Binding Protein-1, Prolactin and Progesterone Receptor Mrna and Protein During the Implantation Phase in Human Endometrium

[Apoptosis and Expression of Relative Genes in Early Pregnant Chorionic Villi and Decidua].

Investigation of the 12-Month Efficacy and Safety of Low-Dose Mifepristone in the Treatment of Painful Adenomyosis

Roles of Mifepristone on the Regulation of Cytotoxic Lymphocytes and Regulatory T Cells.

The Influence of Mifepristone on the Expression of Trophinin,tastin and Bystin in Trophoblastic Cells in Human Placenta

Ultrastructural Changes of Decidua and Chorion in Early Pregnant Women Contracepted by Mifepriston Combined with Heat Clearing Away and Hemostasis Removing Chinese Medicine

Mifepristone (RU486) inducing abortion in a mouse model by regulating innate and adaptive immune responses

Action of mifepristone on the expression of insulin-like growth factor binding protein-1 mRNA and protein during the early luteal phase in the human oviduct.

The Efficacy and Influence Factors Analysis of Mifepristone Combined with Estrogen-Progesterone in the Treatment of Incomplete Abortion

Assessment of effects of mifepristone administration to lactating mice on the development and fertility of their progeny

Impaction of Induced Labour using Mifepristone on Genetic Stability of Pregnant Women

The Effect of Trophoblasts on T Lymphocytes: Possible Regulatory Effector Molecules - A Proteomic Analysis

INHIBITORY EFFECTS OF MIFEPRISTONE ON THE GROWTH OF HUMAN GASTRIC CANCER CELL LINE MKN-45 IN VITRO AND IN VIVO

Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.

Down-regulation of Mir-378A-3p Induces Decidual Cell Apoptosis: a Possible Mechanism for Early Pregnancy Loss

Preliminary study on the effect of mifepristone followed by diffferent regimens of misoprostol for termination of pregnancy between 8 and 16 weeks of gestation

Effects of Mifepristone on Expression of Endothelial Nitric Oxide Synthase in Human Endometrium During the Implantation Phase

Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro